Past Medical History: HTN COPD - used albuterol inhaler Metastatic Melenoma: symptoms [**12-29**] melena DX:[**2-4**] after UGI Bleed when endoscopy showed gastric mass, 2 moles on back bx and confirmed as melenoma.
STAGING: CT Torso - multiple bilateral pulmonary nodules with a dominant mass in the LLL.
LLL mass biopsy c/w melanoma.
PET-CT on [**2101-2-21**] was notable for FDG-avid adenopathy in the mediastinum and left suprahilar region, multiple bilateral lung nodules, multiple liver lesions, a lymph node adjacent to the pancreatic head, and an "extremely" avid lesion in the greater curvature of the mid-body of the stomach.
An MRI of the brain was negative.
TREATMENT: HD IL-2 here at [**Hospital1 18**] from [**Date range (1) 86250**] (received 8 of 14 doses) and [**Date range (1) 86251**]/10 (received 9 of 14 doses).
Family History: Mother - lung cancer, death 30s, she was a smoker  Physical Exam: ON ADMISSION Afebrile, HR 120, BP 110/70, RR 18, O2sat 96% RA General Appearance: Well nourished, No acute distress Eyes / Conjunctiva: PERRL Head, Ears, Nose, Throat: Normocephalic Lymphatic: Cervical WNL, Supraclavicular WNL Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal), No(t) S3, No(t) S4, No(t) Rub, (Murmur: No(t) Systolic, No(t) Diastolic) Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse: Present), (Right DP pulse: Present), (Left DP pulse: Present) Respiratory / Chest: (Percussion: Dullness : left posterior lung field), (Breath Sounds: Clear : anteriorly, Diminished: posterior/lateral, Absent : left posterior lung field, base RLL), chest wall inferior to left nipple palpable subcutaneous nodule approx 1 cm Abdominal: Soft, Bowel sounds present, Tender: RUQ, LUQ, firm, tender liver edge 3 cm below ribs, subcutaneous masses palpable, 2 RUQ ( > 4 cm each), one midline in pubic area, on to left of midline by umbilicus Extremities: Right lower extremity edema: Absent, Left lower extremity edema: Absent, No(t) Cyanosis, No(t) Clubbing Skin:  Warm, No(t) Rash: , 2 scars right upper lateral back, hypopigmented with surrounding sm black round satellite lesions Neurologic: Attentive, Follows simple commands, Responds to: Verbal stimuli, Oriented (to): person, place, reason for admission, date, Movement: Purposeful, Tone: Normal, [**5-25**] hip flexors, biceps symettric.
Pertinent Results: OSH Labs: [**5-25**] Na 133 K 5.4 Cl 94 Co2 25 BUN 12 Cr 0.81 BG 100 AST 73 ALT 73 Tbili 0.9 Alk Phos 600 GGT 339 Albumin 2.6 INR 1.38  WBC 13 HCT 33 (baseline 30-35) at 1400 [**5-25**] PLT 437  OSH Studies: 6 minute walk, resting O2 sat 98%, trending O2 sat 96%, resting HR 103, trending HR 117, walked 100 feet.
OSH Images:  ECHO [**2101-5-25**]: EF 55-60%, LA mild dilated with diameter 43mm, mild MR, mild TR, est PA pressure 22 mmHg, no pericardial effusion.
CTA [**2101-5-21**]: No CT evidence of pulmonary embolus.
Progression from CT [**2101-2-4**] when mass was maximally 5.2 cm.
ON ADMISSION: [**2101-5-25**] 10:11PM BLOOD WBC-11.0 RBC-3.77* Hgb-9.5* Hct-31.0* MCV-82 MCH-25.1* MCHC-30.6* RDW-19.2* Plt Ct-430 [**2101-5-25**] 10:11PM BLOOD Neuts-81.6* Lymphs-11.4* Monos-6.1 Eos-0.9 Baso-0.1 [**2101-5-25**] 10:11PM BLOOD Glucose-90 UreaN-16 Creat-0.6 Na-133 K-4.9 Cl-97 HCO3-23 AnGap-18 [**2101-5-25**] 10:11PM BLOOD ALT-61* AST-65* AlkPhos-547* TotBili-0.9 [**2101-5-25**] 10:11PM BLOOD Albumin-3.1* Calcium-8.9 Phos-3.7 Mg-1.9 [**2101-5-25**] 10:11PM BLOOD Lipase-18  [**2101-5-26**] ECG: Sinus tachycardia, rate 106.
Compared to the previous tracing of [**2101-3-28**] normal sinus rhythm has given way to sinus tachycardia.
It was debridement as possible but stents were not able to be put in.
His follow-up chest xray showed increased aeration of the left lower lobe and the patient had subjective improvement in his dyspnea, although still had difficulty walking or exerting himself without become short of breath.
Your blood count decreased slightly during this admission and you were given a unit of blood prior to discharge.
Changes to your medications: ADDED levofloxacin 750mg by mouth daily for 10 days ADDED OxyCONTIN 20mg by mouth every 12 hours  Followup Instructions: You have the following appointments scheduled in follow-up:  Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 5387**], MD Location: [**Hospital1 18**] [**Hospital Ward Name 516**], [**Hospital Ward Name 23**] Building, Floor 9 Phone: [**Telephone/Fax (1) 22**] Date/Time: [**2101-6-7**] 2:00pm * Please arrive 30-45 minutes prior to your appointment to have your blood drawn at [**Hospital Ward Name 23**] 9.
[**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 22059**] Department: Radiation Oncology at [**Hospital3 328**] Cancer Institute Location: [**Street Address(2) 86252**], [**Location (un) 5871**], MA Phone: [**Telephone/Fax (1) 22062**] Date/Time: Wednesday, [**2101-6-8**] at 10:00AM                                [**Name6 (MD) **] [**Last Name (NamePattern4) 9601**] MD, [**MD Number(3) 9602**]
